985 results on '"Davies, Kay E."'
Search Results
52. Oxr1 improves pathogenic cellular features of ALS-associated FUS and TDP-43 mutations
53. Safety, tolerability, and pharmacokinetics of SMT C1100, a 2-arylbenzoxazole utrophin modulator, following single- and multiple-dose administration to healthy male adult volunteers
54. Neuron-specific antioxidant OXR1 extends survival of a mouse model of amyotrophic lateral sclerosis
55. Syncoilin isoform organization and differential expression in murine striated muscle
56. Survival motor neuron deficiency enhances progression in an amyotrophic lateral sclerosis mouse model
57. The Human Gene Map [and Discussion]
58. Increasing Complexity of the Dystrophin-Associated Protein Complex
59. Happy 30th Birthday, HMG
60. Dysregulation of the Tweak/Fn14 pathway in skeletal muscle of spinal muscular atrophy mice
61. Evaluating the links between schizophrenia and sleep and circadian rhythm disruption
62. Identification of valid housekeeping genes for quantitative RT-PCR analysis of cardiosphere-derived cells preconditioned under hypoxia or with prolyl-4-hydroxylase inhibitors
63. Hsp72 preserves muscle function and slows progression of severe muscular dystrophy
64. Is Good Housekeeping the Key to Motor Neuron Survival?
65. Microarray analysis of mdx mice expressing high levels of utrophin: Therapeutic implications for dystrophin deficiency
66. Generation and Characterization of Transgenic Mice with the Full-length Human DMD Gene
67. Abnormal cardiac morphology, function and energy metabolism in the dystrophic mdx mouse: An MRI and MRS study
68. The Robotic Mouse: Understanding the Role of AF4, a Cofactor of Transcriptional Elongation and Chromatin Remodelling, in Purkinje Cell Function
69. Chondrolectin affects cell survival and neuronal outgrowth in in vitro and in vivo models of spinal muscular atrophy
70. Rescue of skeletal muscle [alpha]-actin--null mice by cardiac (fetal) [alpha]-actin
71. Neuronal over-expression of Oxr1 is protective against ALS-associated mutant TDP-43 mislocalisation in motor neurons and neuromuscular defects in vivo
72. Analysis of skeletal muscle function in the C57BL6/SV129 syncoilin knockout mouse
73. High-throughput analysis of promoter occupancy reveals direct neural targets of FOXP2, a gene mutated in speech and language disorders
74. Mutations in α-Tubulin Cause Abnormal Neuronal Migration in Mice and Lissencephaly in Humans
75. Intermediate filament-like protein syncoilin in normal and myopathic striated muscle
76. The allure of stem cell therapy for muscular dystrophy
77. Behavioural characterisation of the robotic mouse mutant
78. Chapter 7 Spinal muscular atrophies and hereditary motor neuropathies
79. Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment: Third in Molecular Medicine Review Series
80. Pharmacological strategies for muscular dystrophy
81. Cardiac α-actin over-expression therapy in dominant ACTA1 disease
82. Gene expression profiling studies on Caenorhabditis elegans dystrophin mutants dys-1(cx-35) and dys-1(cx18)
83. Engineering Exon-Skipping Vectors Expressing U7 snRNA Constructs for Duchenne Muscular Dystrophy Gene Therapy
84. Immunogold Confirmation that Utrophin is Localized to the Normal Position of Dystrophin in Dystrophin-negative Transgenic Mouse Muscle
85. Identification and Characterization of Murine SCARA5, a Novel Class A Scavenger Receptor That Is Expressed by Populations of Epithelial Cells
86. Treating Muscular Dystrophy with Stem Cells?
87. Testing of SHIRPA, a mouse phenotypic assessment protocol, on Dmd mdx and Dmd mdx3cv dystrophin-deficient mice
88. Advisory Board
89. Function and Genetics of Dystrophin and Dystrophin-Related Proteins in Muscle
90. Muscular Dystrophy --Reason for optimism?
91. Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping
92. Muscular Dystrophies Related to the Cytoskeleton/Nuclear Envelope
93. Progress in therapy for Duchenne muscular dystrophy
94. Therapeutic approaches to muscular dystrophy
95. Mouse models of dominant ACTA1 disease recapitulate human disease and provide insight into therapies
96. Diaphragm rescue alone prevents heart dysfunction in dystrophic mice
97. Verifying nomenclature of DNA variants in submitted manuscripts: Guidance for journals
98. Decreasing HepG2 Cytotoxicity by Lowering the Lipophilicity of Benzo[d]oxazolephosphinate Ester Utrophin Modulators
99. Highway to HHGE: An Interview with Dame Kay E. Davies
100. The Long Journey from Diagnosis to Therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.